These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7965818)

  • 1. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids.
    Young AM; Masaki MA; Geula C
    J Pharmacol Exp Ther; 1992 Apr; 261(1):246-57. PubMed ID: 1560372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
    Walker EA; Butelman ER; DeCosta BR; Woods JH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):280-6. PubMed ID: 7901396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to morphine-like stimulus effects of mu opioid agonists.
    Young AM; Kapitsopoulos G; Makhay MM
    J Pharmacol Exp Ther; 1991 May; 257(2):795-805. PubMed ID: 2033521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
    Comer SD; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):866-74. PubMed ID: 8246161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects on enadoline in pigeons.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1996 May; 277(2):960-7. PubMed ID: 8627579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL; McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine.
    Walker EA; Richardson TM; Young AM
    Psychopharmacology (Berl); 1996 May; 125(2):113-9. PubMed ID: 8783384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
    France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.